News

Latest Articles and Events

Numera’s Herd Immunity Tracker: EZ continues to lead the way

August 6, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, August 6, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Apart from the stalled vaccination campaign in the US, developed markets are still making headway towards ‘herd’ immunity. While the projected time for the US remains above 4.5 months, other DMs have cut back the projected timeline by 10% this past week to 1.2 months. Elsewhere, fears over the Delta variant are causing vaccination campaigns to accelerate, with significant progress recorded in most major emerging economies.

Read More

Numera’s Herd Immunity Tracker: Delta revitalizes campaigns

July 30, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, July 30, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Global vaccination rates picked up this past week amid a growing sense of urgency to minimize the impact of the highly infectious Delta variant. At the current pace of inoculation, the world is now 3.5 months away from surpassing the 70%+ immunity threshold. Most major economies cut back their projected timeline by double digits, led by 30%+ gains in Canada and China (now less than one month away from the 70% threshold).

Read More

Numera’s Herd Immunity Tracker: The race against Delta

July 23, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, July 23, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

The advent of the Delta COVID variant is creating a renewed sense of urgency around the speed of vaccination campaigns. Clinical and epidemiological data reveals Delta is much more transmissible than previous mutations, and explains the bulk of new COVID cases in Europe and Asia. The highly infectious nature of the Delta variant means countries with low vaccination rates could experience a much more disruptive ‘third’ wave.

Read More

Numera’s Herd Immunity Tracker: A mixed bag

July 16, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, July 16, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Global vaccination campaigns have stalled in July, primarily owing to a slower pace of inoculation in emerging economies. At current rates of vaccination, the world should attain 70%+ immunity by the end of November. Importantly, the global average hides considerable heterogeneity by region. While developed markets should surpass the 70% immunity threshold in less than two months, emerging markets will only achieve that objective by year-end.

Read More

Numera’s Herd Immunity Tracker: Emerging market progress stalls

July 9, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, July 9, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Global vaccination campaigns stalled over the past week, increasing the projected time towards 70%+ immunity by 5.2% to 4 months. Importantly, all of the slowdown stemmed from emerging markets, where the vaccination rate stalled after two months of near-continuous improvements. In contrast, developed market maintained their daily pace of inoculations steady at 1.3 doses per hundred people, cutting back the projected timeline by 6.7% to two months.

Read More